These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15866675)

  • 41. Long-term outcome of ABO-incompatible living-donor liver transplantation: a single-center experience.
    Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
    J Hepatobiliary Pancreat Surg; 2009; 16(4):468-72. PubMed ID: 19333538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful ABO-incompatible heart transplantation in a child despite blood-group sensitization after ventricular assist device support.
    Urschel S; Dalla Pozza R; Loeff M; Schmitz C; Sodian R; Schmoeckel M; Kowalski C; Netz H
    Pediatr Transplant; 2009 Sep; 13(6):773-6. PubMed ID: 19170929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients.
    Hwang S; Lee SG; Moon DB; Song GW; Ahn CS; Kim KH; Ha TY; Jung DH; Kim KW; Choi NK; Park GC; Yu YD; Choi YI; Park PJ; Ha HS
    Liver Transpl; 2010 Apr; 16(4):482-90. PubMed ID: 20222052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current status of ABO-incompatible kidney transplantation in children.
    Shishido S; Hasegawa A
    Pediatr Transplant; 2005 Apr; 9(2):148-54. PubMed ID: 15787785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: a proposal for grading the severity of antibody-mediated rejection.
    Morioka D; Togo S; Kumamoto T; Takeda K; Matsuo K; Inayama Y; Yamanaka S; Tanaka K; Endo I; Maegawa J; Shimada H
    Transplantation; 2008 Jan; 85(2):171-8. PubMed ID: 18212620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [ABO-incompatible liver transplantation for liver failure].
    Yang Y; Xu C; Chen YH; Lu MQ; Cai CJ; Li H; Wang GS; Yi SH; Zhang J; Yi HM; Zhang JF; Jiang N; Zhao H; Li X; Li MR; Chen GH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2833-6. PubMed ID: 18167286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modified laparoscopic splenectomy: a beneficial technique for ABO-incompatible living donor renal transplantation candidates on hemodialysis.
    Matsuoka S; Uchida K; Tominaga Y; Uno N; Simabukuro S; Hiramitsu T; Goto N; Sato T; Nagasaka T; Watarai Y
    Ther Apher Dial; 2008 Oct; 12(5):381-4. PubMed ID: 18937721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved graft survival in ABO-incompatible living donor kidney transplantation.
    Kaihara S; Okamoto M; Akioka K; Ogino S; Higuchi A; Kadotani Y; Nobori S; Yoshimura N
    Transplant Proc; 2005 May; 37(4):1804-5. PubMed ID: 15919472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
    Yoshizawa A; Sakamoto S; Ogawa K; Kasahara M; Uryuhara K; Oike F; Ueda M; Takada Y; Egawa H; Tanaka K
    Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver transplantation with ABO incompatible graft under immunoadsorption protocol--case report.
    Markiewicz-Kijewska M; Kaliciński P; Teisseyre J; Ismail H; Ostoja-Chyzyńska A; Prokurat S; Sokolnicka I
    Ann Transplant; 2010; 15(4):68-71. PubMed ID: 21183879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Segmental ABO-incompatible liver graft from a donor after cardiac death in neonatal acute liver failure.
    Gelas T; Hartley J; Mirza DF; Muiesan P; Bowen C; Sharif K
    Pediatr Transplant; 2012 Mar; 16(2):E53-7. PubMed ID: 21790917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of immunomodulation in ABO-incompatible adult liver transplant recipients.
    Urbani L; Mazzoni A; Bianco I; Grazzini T; De Simone P; Catalano G; Montin U; Petruccelli S; Morelli L; Campani D; Pollina L; Biancofiore G; Bindi L; Tascini C; Menichetti F; Scatena F; Filipponi F
    J Clin Apher; 2008; 23(2):55-62. PubMed ID: 18186527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers.
    Demetris AJ; Jaffe R; Tzakis A; Ramsey G; Todo S; Belle S; Esquivel C; Shapiro R; Markus B; Mroczek E
    Am J Pathol; 1988 Sep; 132(3):489-502. PubMed ID: 3046369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation.
    Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Fujimori K; Sato T; Satomi S
    Ther Apher Dial; 2007 Oct; 11(5):319-24. PubMed ID: 17845390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What is the best immunosuppression in living donor liver transplantation?
    Ringe B; Moritz M; Zeldin G; Soriano H
    Transplant Proc; 2005 Jun; 37(5):2169-71. PubMed ID: 15964369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody-mediated rejection: hyperacute rejection reality in liver transplantation? A case report.
    Della-Guardia B; Almeida MD; Meira-Filho SP; Torres MA; Venco F; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2008 Apr; 40(3):870-1. PubMed ID: 18455039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.